New York State Common Retirement Fund
BLPH

New York State Common Retirement Fund’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

New York State Common Retirement Fund’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37
Closed – – 3664
2021
Q2 		$0 Sell
37
-263
-88% -$1.18K ﹤0.01% 3626
2021
Q1 		$2K Hold
300
– – ﹤0.01% 3286
2020
Q4 		$2K Hold
300
– – ﹤0.01% 3261
2020
Q3 		$3K Sell
300
-7,700
-96% -$90.5K ﹤0.01% 3224
2020
Q2 		$100K Buy
+8,000
New +$112K ﹤0.01% 2951

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

New York State Common Retirement Fund's BLPH Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2021, closing a stake of 37 shares.

New York State Common Retirement Fund first reported a position in BLPH in Q2 2020 and held it in 5 quarters. The position peaked at $100K in Q2 2020. 22 funds tracked by Wall St. Rank hold BLPH as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 37 Bellerophon Therapeutics, Inc. shares in Q3 2021.
  • New York State Common Retirement Fund first reported a position in Bellerophon Therapeutics, Inc. in Q2 2020 and held it in 5 quarters.
  • New York State Common Retirement Fund's Bellerophon Therapeutics, Inc. position peaked at $100K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.